Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2024 Jan 30;12(1):e004762corr1. doi: 10.1136/jitc-2022-004762corr1

Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

PMCID: PMC10828831  PMID: 38290771

Ju F, Luo Y, Lin C, et al. Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade. J ImmunoTher Cancer 2022;10:e004762. doi: 10.1136/jitc-2022-004762

In figure 1K, the legend has been amended to the icon ∇ for ‘Naïve mice', and to the icon ∆ for ‘Cured mice’.

graphic file with name jitc-2022-004762corr1ilf02.jpg


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES